Publicaciones en colaboración con investigadores/as de Hospital Universitario Reina Sofia (16)

2023

  1. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)

    Nefrologia, Vol. 43, pp. 1-36

2022

  1. Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum

    Clinical journal of the American Society of Nephrology : CJASN

  2. Loss of humoral response 3 months after SARS-CoV-2 vaccination in the CKD spectrum: the multicentric SENCOVAC study

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 5, pp. 994-999

  3. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)

    Nefrologia, Vol. 42, pp. 1-37

2021

  1. Control of phosphorus and prevention of fractures in the kidney patient

    Nefrologia, Vol. 41, Núm. 1, pp. 7-14

2019

  1. Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice-Vie-KinD study

    PLoS ONE, Vol. 14, Núm. 9

2018

  1. Higher proportion of non-1-84 PTH fragments in peritoneal dialysis patients compared to hemodialysis patients using solutions containing 1.75 mmol/l calcium

    Frontiers in Physiology, Vol. 9, Núm. NOV

2017

  1. Eculizumab in secondary atypical haemolytic uraemic syndrome

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 466-474

2014

  1. Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection

    Journal of Clinical Microbiology, Vol. 52, Núm. 8, pp. 3053-3056

  2. La menor proporción de parathormona circulante biológicamente activa en diálisis peritoneal no permite el ajuste intermétodo de parathormona establecida para hemodiálisis

    Nefrologia, Vol. 34, Núm. 3, pp. 330-340

2013

  1. Correction of hypocalcemia allows optimal recruitment of FGF-23-dependent phosphaturic mechanisms in acute hyperphosphatemia post-phosphate enema

    Journal of Bone and Mineral Metabolism, Vol. 31, Núm. 6, pp. 703-707

2011

  1. Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients

    Nephrology Dialysis Transplantation, Vol. 26, Núm. 8, pp. 2567-2571

2008

  1. Occult hepatitis C virus infection among hemodialysis patients

    Journal of the American Society of Nephrology, Vol. 19, Núm. 12, pp. 2288-2292

2007

  1. Course of vascular access and relationship with treatment of anemia

    Clinical Journal of the American Society of Nephrology, Vol. 2, Núm. 6, pp. 1163-1169

2004

  1. Guías de gestión de calidad del líquido de diálisis (LD)

    Nefrologia, Vol. 24, Núm. SUPPL.2, pp. 1-42

  2. Guías sobre enfermedades víricas en hemodiálisis (HD)

    Nefrologia, Vol. 24, Núm. SUPPL.2, pp. 43-66